Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Medtronic Inc (MDT)

Medtronic Inc (MDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 170,841,296
  • Shares Outstanding, K 1,348,073
  • Annual Sales, $ 30,117 M
  • Annual Income, $ 3,606 M
  • 60-Month Beta 0.79
  • Price/Sales 5.62
  • Price/Cash Flow 26.73
  • Price/Book 3.22
Trade MDT with:

Options Overview

Details
  • Implied Volatility 17.28%
  • Historical Volatility 16.86%
  • IV Percentile 4%
  • IV Rank 6.54%
  • IV High 40.07% on 10/30/20
  • IV Low 15.68% on 04/16/21
  • Put/Call Vol Ratio 0.37
  • Today's Volume 5,283
  • Volume Avg (30-Day) 6,920
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 120,715
  • Open Int (30-Day) 137,566

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 07/31/21
See More
  • Average Estimate 1.31
  • Number of Estimates 13
  • High Estimate 1.32
  • Low Estimate 1.31
  • Prior Year 0.62
  • Growth Rate Est. (year over year) +111.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
120.53 +5.14%
on 06/08/21
129.15 -1.87%
on 05/25/21
-0.56 (-0.44%)
since 05/21/21
3-Month
114.78 +10.41%
on 03/25/21
132.30 -4.21%
on 04/29/21
+9.89 (+8.46%)
since 03/22/21
52-Week
87.68 +44.54%
on 06/25/20
132.30 -4.21%
on 04/29/21
+33.40 (+35.79%)
since 06/22/20

Most Recent Stories

More News
First Procedure in the World with Medtronic Hugo™ Robotic-Assisted Surgery System Performed at Clínica Santa Maria in Chile

/PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first patient procedure with the Hugo™ robotic-assisted surgery (RAS) system. The robotic prostatectomy...

MDT : 126.73 (+0.95%)
USD 24.01 Billion, Wound Care Market [2021-2028] | Size, Share, Growth, Trends, Revenue, Analysis, Competitive Landscape, Forecast Report

The global wound care market size is expected to gain momentum by reaching USD 24.01 billion by 2028 while exhibiting a CAGR of 6.1% between 2021 and 2028. Fortune Business Insights in its report, titled...

MDT : 126.73 (+0.95%)
PLHNF : 452.7100 (+1.96%)
Trauma Fixation Devices And Equipment Global Market Report 2021: COVID-19 Impact And Recovery To 2030

Reportlinker.com announces the release of the report "Trauma Fixation Devices And Equipment Global Market Report 2021: COVID-19 Impact And Recovery To 2030" - https://www.reportlinker.com/p06097018/?utm_source=GNW...

MDT : 126.73 (+0.95%)
SNN : 43.25 (+0.32%)
SYK : 262.74 (+1.16%)
World's First Heart Valve Replacement Using Extended Reality Platform Brings the Operating Room to the Remote Surgical Specialist for Virtual Support During Live Procedures

COMTEX_388629326/2669/2021-06-21T18:00:31

MDT : 126.73 (+0.95%)
Medtronic Receives FDA Expanded Approval for Arctic Front™ Family of Cardiac Cryoablation Catheters for Initial Use for Recurrent Symptomatic Paroxysmal Atrial Fibrillation

- First and Only Approval to Indicate Cryoablation as an Initial Rhythm Control Strategy - Offers Safe, Effective Alternative to Antiarrhythmic Drug Therapy for the Prevention of Atrial Arrythmia Recurrence ...

MDT : 126.73 (+0.95%)
Cardiology Space Gains Momentum in 2021: 5 Stocks to Focus on

These cardiology device stocks Medtronic (MDT), Boston Scientific (BSX), Edwards Lifesciences (EW), Merit Medical (MMSI), BD (BDX) are expected to continue their run over the next few months.

ABT : 110.96 (-0.43%)
BSX : 43.83 (+0.53%)
BDX : 240.32 (-0.21%)
MDT : 126.73 (+0.95%)
EW : 104.52 (+1.63%)
MMSI : 62.25 (+1.09%)
Global AI in Healthcare Market (2021 to 2026) - by Sections, Diagnosis, End-user and Geography

/PRNewswire/ -- The report has been added to offering.

GOOGL : 2,446.61 (+0.43%)
IRMTF : 23.2491 (+10.00%)
INTC : 55.87 (unch)
IBM : 146.36 (-0.20%)
MDT : 126.73 (+0.95%)
MSFT : 265.51 (+1.10%)
SIEGY : 81.6600 (-0.01%)
Global Sports Medicine Market Showing Signs of Recovery Post COVID-19--Projected to Reach USD 8.20 Billion by 2027

A study recently conducted by the strategic consulting and market research firm, BlueWeave Consulting revealed that the global sports medicine market was worth USD 5.19 billion in 2020 and is further projected...

GSPT : 0.8990 (+38.31%)
MDT : 126.73 (+0.95%)
OSSFF : 7.6000 (+7.80%)
SNN : 43.25 (+0.32%)
WMGIZ : 0.01 (unch)
Global Pulse Oximeters Market (2021 to 2026) - Featuring Medtronic, Smiths Medical and GE Healthcare Among Others

The "Pulse Oximeters Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.

MDT : 126.73 (+0.95%)
First U.S. Lawsuit Filed Against Aziyo Biologics, Inc. And Medtronic, Inc. On Behalf Of Delaware Patient Infected With Tuberculosis After Receiving Tainted Surgical Bone Graft Product During Spinal Fusion

/PRNewswire/ -- A retired career corrections officer, who contracted tuberculosis (TB) during a spinal fusion operation, today filed the first lawsuit against biotechnology company Aziyo, Inc., that...

FSNN : 0.0580 (-19.44%)
MDT : 126.73 (+0.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders...

See More

Key Turning Points

3rd Resistance Point 128.78
2nd Resistance Point 127.95
1st Resistance Point 127.34
Last Price 126.73
1st Support Level 125.90
2nd Support Level 125.07
3rd Support Level 124.46

See More

52-Week High 132.30
Last Price 126.73
Fibonacci 61.8% 115.26
Fibonacci 50% 109.99
Fibonacci 38.2% 104.72
52-Week Low 87.68

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar